These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39025730)

  • 1. Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Thuluvath AJ; Kim M; Peipert J; Duarte-Rojo A; Huang A; Siddiqui O; Nizamuddin M; Dietch Z; Levitsky J; Ladner DP
    Transplant Proc; 2024; 56(6):1378-1384. PubMed ID: 39025730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cognition predicts the risk of hospitalization and death in cirrhosis.
    Kim M; Liotta EM; Zee PC; Ganger DR; Ladner DP; Karmarkar A; Peipert JD; Sorond FA; Prabhakaran S; Reid KJ; Naidech AM; Maas MB
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2282-2290. PubMed ID: 31631586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
    Bajaj JS; Thacker LR; Heuman DM; Sterling RK; Stravitz RT; Sanyal AJ; Luketic V; Fuchs M; Gilles HC; Wade JB
    Liver Transpl; 2012 Oct; 18(10):1179-87. PubMed ID: 22674517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
    Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant Candidates.
    Thuluvath AJ; Duarte-Rojo A; Lai JC; Peipert J; Dietch ZC; Siddiqui O; Morrissey S; Belfanti K; Zhao L; Guo K; Nizamuddin M; Polineni P; Levitsky J; Flores AM; Ladner DP
    Transplantation; 2024 Feb; 108(2):491-497. PubMed ID: 37496147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
    Garcia-Martinez R; Rovira A; Alonso J; Jacas C; Simón-Talero M; Chavarria L; Vargas V; Córdoba J
    Liver Transpl; 2011 Jan; 17(1):38-46. PubMed ID: 21254343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Cerebral Hemodynamics in Patients With Cirrhosis After Liver Transplantation.
    Macías-Rodríguez RU; Ruiz-Margáin A; Cantú-Brito C; Flores-Silva DF; García-Flores OR; Cubero FJ; Larrieta-Carrasco E; Torre A
    Liver Transpl; 2018 Dec; 24(12):1673-1679. PubMed ID: 30207422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Encephalopathy Is Reversible in the Long Term After Liver Transplantation.
    Hopp AE; Dirks M; Petrusch C; Goldbecker A; Tryc AB; Barg-Hock H; Strassburg C; Klempnauer J; Weissenborn K; Pflugrad H
    Liver Transpl; 2019 Nov; 25(11):1661-1672. PubMed ID: 31437344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
    Bajaj JS; Riggio O; Allampati S; Prakash R; Gioia S; Onori E; Piazza N; Noble NA; White MB; Mullen KD
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1511-6. PubMed ID: 23707462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis.
    Bajaj JS; Lai JC; Tandon P; O'Leary JG; Wong F; Garcia-Tsao G; Vargas HE; Kamath PS; Biggins SW; Limon-Miro A; Shaw J; Mbachi C; Chew M; Golob Deeb J; Thacker LR; Reddy KR
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1864-1872.e2. PubMed ID: 36328307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
    Formentin C; De Rui M; Zoncapè M; Ceccato S; Zarantonello L; Senzolo M; Burra P; Angeli P; Amodio P; Montagnese S
    J Hepatol; 2019 Apr; 70(4):648-657. PubMed ID: 30633946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.
    Stine JG; Stukenborg GJ; Wang J; Adkins A; Niccum B; Zimmet A; Argo CK
    Ann Hepatol; 2020; 19(1):62-68. PubMed ID: 31558420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.
    Tapper EB; Baki J; Parikh ND; Lok AS
    Hepatology; 2019 Apr; 69(4):1676-1685. PubMed ID: 30382584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.